• Our Bursary Scheme grants are up to £1000 to support the specified activities. This is a pilot scheme, running for 1 year in the first instance. If an award is made, it will be based on an estimation of costs.
• The sum awarded will depend on the estimated costs provided in the application form. Recipients of an award must submit receipts following the event. Any overpayment must be repaid to the Epilepsy Research Institute.
• For this pilot scheme, our Capacity Building Theme Leads will evaluate applications on a quarterly basis, according to the following schedule. We will aim to notify you of the outcome of your application within 5 working days of the decision meeting.
Window Submission deadline (5pm) Decision
1 18 August 2025 1 September 2025
2 1 December 2025 15 December 2025
3 23 February 2026 1 March 2026
4 18 May 2026 1 June 2026
• Recipients of awardswill be expected to write a 300–500-word reflection, which may be posted on the Hub or Institute webpage.
• If you receive an award and are subsequently unable to attend the event, you must notify us and return the money. You cannot carry forward an award to pay for another meeting or event.
1. Clear Relevance to Epilepsy — Across Many Dimensions (Biological, Clinical, Public Health, Technology)
ERI-UK funds research into “causes, prevention and treatment of epilepsy and associated conditions”.
Their funding spans a broad spectrum: neurodevelopment, disease mechanisms, advanced therapeutics/disease modification, mortality/risk (including SUDEP), hormones/reproduction, enabling technologies (e.g. devices, diagnostics) — reflecting a commitment to diversity of research.
Proposals that address unmet needs or community-identified priorities carry extra strength. The Institute’s research themes align with priorities identified by a patient and professional Priority Setting Partnership.
Predictor: Epilepsy must be central — from pathology and mechanisms to patient-facing outcomes or technology for management/diagnostics.
2. Fit With the Grant Mechanism (Career Stage + Project Maturity + Risk Level)
ERI-UK offers different grant types:
| Mechanism | Best For / What It Supports |
|---|---|
| Explore Pilot Grant (small, short-term) | Early-stage or high-risk ideas needing pilot data. |
| Endeavour Project Grant (mid-size, ~3 years) | Well-developed hypotheses with some preliminary data; more ambitious scope. |
| Emerging Leader Fellowship / Fellowship Awards | Early/mid-career researchers building independence. |
| PhD Studentships / Doctoral-training funding (co-funded) | Training the next generation — for investigators at doctoral/early post-doc stage. |
Predictor: Match your career stage + project maturity to the correct grant type. Over-scoped early proposals or under-developed senior proposals tend to be penalized.
3. Preliminary Data or Strong Rationale (Especially for Non-Pilot Grants)
For larger grants like the Endeavour Project Grant, the Institute expects a hypothesis based on pilot data.
Even when applying for pilot funding, proposals with a clearly plausible rationale and feasibility plan tend to fare better than speculative ideas without justification.
Predictor: Demonstrable feasibility — either via pilot data or a robust plan — significantly raises reviewer confidence.
4. Alignment With Community-Defined Priorities & Patient Involvement (“PPIE / Shape Network”)
ERI-UK explicitly incorporates patient and public involvement through their “Shape Network.” Shortlisted applications go through clinics with people affected by epilepsy to review relevance and design.
Their guiding research roadmap is built on priorities identified by a broad community using the formal Priority Setting Partnership methodology.
Predictor: Applications that articulate how they address patient-identified needs, include PPIE (patient involvement) and consider real-world relevance have a strong advantage.
5. Multidisciplinary / Collaborative Approach & Translational Vision
ERI-UK’s strategy emphasizes “convene, connect and capacity-build the epilepsy research ecosystem”, promoting collaborations among academia, NHS, industry, patient organizations, funders.
Projects that combine basic neuroscience, clinical neurology, engineering (devices), data science, epidemiology, or social science are well aligned.
Translational ambition — for example, imaging, biomarkers, neuromodulation devices, SUDEP risk reduction, patient-centered outcomes — is highly valued.
Predictor: Team-based, interdisciplinary proposals with clear translation pathways (bench → clinic → patient benefit) tend to score higher.
6. Realistic, Well-Defined Aims and Clear Milestones
Because ERI-UK funds projects ranging from small pilots to full-scale grants:
Strong proposals typically lay out 2–3 clearly defined aims, with realistic timelines and milestones across the grant duration.
Risk mitigation and fallback plans (especially for high-risk research) improve credibility.
For pilot grants, a reasonable scope that can yield publishable/preliminary data is critical.
Predictor: Feasible scope and clear deliverables are strongly preferred — overly ambitious or vague proposals often struggle.
7. Strong Investigator & Institutional Credentials
For Emerging Leader or larger project grants, reviewers expect investigators with relevant background, capacity to lead, and institutional support/GMP cores if needed.
Institutions must support applications, and many funders (including ERI-UK) expect institutions to limit internal submissions, which encourages internal vetting and strengthens competitiveness.
Predictor: A credible PI/institutional track record and proper support infrastructure matter — especially for larger or longer-term awards.
8. Ethical, Inclusive, and Patient-Focused Design when Relevant
Given epilepsy’s clinical and social complexity, proposals involving human participants or patient data must include:
Ethical approvals / plan for participant safety
Inclusion of patient-experience or quality-of-life measures where relevant
Consideration of comorbidities, diversity, and equity in recruitment/design
Predictor: Clear, ethically robust design with patient-centred outcomes strengthens proposals — especially clinical or public-health–oriented ones.
9. Value for Money & Realistic Budgeting (Given Limited Charity Grant Size)
ERI-UK invests roughly £1.7–2 million annually in research grants.
Given finite resources, proposals that deliver maximal scientific or patient-relevant return per pound invested tend to stand out.
Pilot or feasibility studies must justify expenses carefully — reviewers are sensitive to cost vs. potential impact.
Predictor: Lean, cost-effective budgets aligned with aims — avoid over-budgeting or requesting unnecessary overheads.
10. Good Writing & Clear Communication — Accessible to Multi-Disciplinary Reviewers
Funders like ERI-UK often evaluate proposals through panels combining basic scientists, clinicians, and people with lived experience. Clear, well-structured proposals with accessible language, solid rationale, and transparent methods help make a strong impression.
Emphasizing “why this matters” (patient benefit, unmet need, translation potential) is as important as scientific novelty.
Predictor: Good grant-writing quality — clarity, impact, organized presentation — often distinguishes funded versus unfunded applications.
If you’re preparing a proposal to the Epilepsy Research Institute UK, you should:
Ensure epilepsy (or a related condition) is at the core of your research question — not peripheral.
Choose the correct grant mechanism that matches your career stage and project maturity.
Build a feasible 2–3 aim plan with clear milestones and realistic scope.
Use or plan to generate preliminary data or a very strong theoretical foundation.
Include a patient/public-involvement (PPIE) component where possible, showing patient-centered design or outcomes.
Embrace multidisciplinary and translational aspects — e.g. combining neuroscience, clinical neurology, data science, device development, etc.
Present clear ethical considerations and inclusion strategy (for human studies).
Prepare a lean and justified budget, maximizing value per pound.
Emphasize impact — for patients, for the epilepsy community, for future research — not just academic novelty.
Write clearly and compellingly, mindful that reviewers may come from diverse backgrounds (basic science, clinical, patient advocacy).
Applications for funding will be considered if the eligibility criteria are satisfied by meeting one or both of the following categories:
A. Attendance at a national or international conference in an epilepsy-related research area: travel, accommodation, and conference fees.
B. Attendance at a training course to acquire skills related to the individual’s epilepsy-related research area: travel, accommodation if needed, training costs.
Sponsor Institute/Organizations: Epilepsy Research Institute UK
Sponsor Type: Corporate/Non-Profit
Address: Churchill House 35 Red Lion Square London WC1R 4SG 020 3882 9438
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Window Submission deadline (5pm) Applications considered 1 18 August 2025 1 September 2025 2 1 December 2025 15 December 2025 3 23 February 2026 1 March 2026 4 18 May 2026 1 June 2026
$1,000
Affiliation: Epilepsy Research Institute UK
Address: Churchill House 35 Red Lion Square London WC1R 4SG 020 3882 9438
Website URL: https://epilepsy-institute.org.uk/eri/research/travel-and-training-awards/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.